Pure Healthcare, the Salt Lake City parent company of Pure Infusion Suites, has announced changes to its senior leadership team. Joshua D. Smith has been appointed CEO and Joshua T. Tandy, who has been acting CEO, will continue as a member of the company’s board of directors.
Pure Infusion provides medical infusions and injections in private suites in Montana, Idaho, Colorado, Washington, Oregon, Nevada and Utah.
Smith has more than 15 years of senior management experience, including over a decade leading strategic development and strategy at national healthcare services companies. In less than a year as chief growth and strategy ffficer for Pure, he oversaw the expansion of the company into three states, helped to develop and open two specialty medical clinics and was largely responsible for a year-over-year revenue increase of over 600 percent, the company said.
Prior to joining Pure, Smith was vice president of strategy and business development at Multispecialty Physician Partners an outpatient infusion services company. Before that, he was a director at Davita Healthcare Partners.
“Josh is the right leader for Pure,” said Tandy. “Josh’s extensive healthcare background and business development skills will help Pure strengthen channel partnerships, develop strategic alliances and expand our ambulatory infusion center footprint.”
“I am very excited to be taking on this new role at Pure,” said Smith. “I believe we have a great business model and a talented management team that uniquely positions us to capitalize on the changing biologic infusion industry. Our mission to provide an exceptional patient experience while simultaneously reducing the high cost of infusion therapy to both the patient and health plans are a powerful force to drive positive change in this part of healthcare.”
Pure also announced that Aaron “Trey” Gardner, current chief business development officer, will assume the role of chief growth officer and Daniel Smith, senior vice president of operations, has been promoted to chief operations officer.